You are here: Home > Strategic National Stockpile > CHEMPACK > Enterprise CHEMPACK
Enterprise CHEMPACK
Enterprise CHEMPACK
The CHEMPACK program is an ongoing initiative of CDC's Division of Strategic National Stockpile (DSNS) launched in 2003, which provides antidotes (three countermeasures used concomitantly) to nerve agents for pre-positioning by State, local, and/or tribal officials throughout the U.S. The proposed Enterprise CHEMPACK program would build upon the existing system, improving it by adding an education, training, and exercise component and by optimizing the pre-positioning of antidotes. The Enterprise CHEMPACK Program is envisioned as a comprehensive capability for the effective use of medical countermeasures in the event of an attack on civilians with nerve agents. Clinical competency, logistics and operations, including training of responders and pre-positioning of countermeasures, as well as the formulary, are addressed.
Proposed Enterprise CHEMPACK program includes:
- Education, training and exercises
- Far forward pre-positioning of antidotes
- Improvements to formulary as next generation medical countermeasures become available
Integrated Program Team (IPT)
- Description:
- Develop overall strategies for developing, acquiring, deploying and using the high priority medical countermeasures identified in the HHS Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Implementation Plan or by request of the Enterprise Executive Committee.
- Membership:
- Interagency Subject Matter Experts; chaired by The Biomedical Advanced Research and Development Authority (BARDA)
- Deliverables:
- Monitor Medical Countermeasures (MCM) developmental pipeline (tech watch)
- Threat-specific BARDA Medical Countermeasure Plan
- Annual progress reports
- Receive reports from Project Coordinating Teams (PCT) and alert Enterprise Executive Committee to any significant delay or change in the projected schedule